Aridis Pharmaceuticals

August 8, 2017August 8, 2017

Aridis Is Enrolling Patients in Pivotal Trial of Its Antibiotic-resistant Pneumonia Therapy Aerucin

News, Pneumonia

Aridis Pharmaceuticals has begun enrolling patients in what it says will be a pivotal clinical trial of its antibiotic-resistant pneumonia therapy Aerucin. The trial will cover Aerucin’s ability to combine with standard ... Read more

January 12, 2017January 12, 2017

CFF Therapeutics Awards Aridis Grant to Advance Therapy for Lung Infections

Cystic Fibrosis, News

Cystic Fibrosis Foundation Therapeutics (CFFT), the drug discovery and development affiliate of the Cystic Fibrosis Foundation (CFF), has awarded Aridis Pharmaceuticals a grant to support the clinical development of Panaecin (gallium ... Read more